Global Rabies Vaccine Market Share

Statistics for the 2023 & 2024 Global Rabies Vaccine market share, created by Mordor Intelligence™ Industry Reports. Global Rabies Vaccine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Rabies Vaccine Industry

The major market players are focusing on technological advancements and pet care initiatives in collaboration with hospitals and government channels. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Zoetis Inc., Merck & Co., Inc., Sanofi SA, Elanco, and Virbac, among others.

Rabies Vaccine Market Leaders

  1. Zoetis Inc.

  2. Merck & Co., Inc

  3. Elanco

  4. Sanofi SA

  5. Boehringer Ingelheim International GmbH

*Disclaimer: Major Players sorted in no particular order

Berna Biotech Ltd, GlaxoSmithKline plc, Merck & Co Inc, Novartis AG, Pfizer Inc, Sanofi SA, Zoetis Inc., Elanco

Rabies Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)